IMS – The Impact of Biosimilar Competition (2015)

1 November 2015

Report

This document sets out to describe the effects on price, […]

IGES Report: Value of Generic Medicines – Health Economics Study, Berlin, 5 October 2015

5 October 2015

Report

To consult the infographics, please click here.

EGA Vision 2015

19 July 2015

Report

To view the full report, please click here.

IMS Health 2015: The Role of Generic Medicines in Sustaining Healthcare Systems: A European Perspective, June 2015

1 June 2015

Report

To view the full report, click here To view the […]

Regulatory Efficiency Report

10 March 2015

Report

GfK – Factors Supporting a Sustainable European Biosimilar Medicines Market

9 September 2014

Report

A study about the future sustainability of the biosimilar medicines […]

KPMG Report: Advice on the implementation of EU-Directive 2011/62/EU

22 February 2013

Report

According to the European Commission (hereinafter ‘EC’) of the European […]

EGA Q&A on the Revised EMA Bioequivalence Requirement

22 June 2010

Report

Generic Medicines: Essential Contributor to the Long-Term Health of Society

21 March 2010

Report

Patent-Related Barriers to Market Entry for Generic Medicines in the European Union

30 June 2009

Report